Effect of parenteral glutamine on the restoration of the lymphocytes sub-population after high-dosage chemotherapy with autologous transplantation of haemotopoietic cells: Data from a double blind randomized study;Vliv parenterálního glutamínu na obnovu lymfocytárnínch subpopulací po vysokodávkované chemoterapii s autologní transplantací krvetvormýnch buněk: Data z dvojitě slepě randomizované studie

Epidemiologie, Mikrobiologie, Imunologie

Volumn 51, Issue 4, 2002, Pages 152-155

  Pytlik R ^a   Gregora, E ^b   Benes P ^c   Kozak T ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c Interni Oddelenci Nemocnice Homolce   (Czech Republic)

Author keywords

Autologous transplantation; Flow cytometry; Glutamine; Lymphocytes

Indexed keywords

ALANYLGLUTAMINE; BUSULFAN; CARBOPLATIN; CARMUSTINE; CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD57 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; GLUTAMINE; IFOSFAMIDE; MELPHALAN; MITOXANTRONE; PLACEBO; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MEGADOSE; FEMALE; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LYMPHOCYTE SUBPOPULATION; MALE; STATISTICAL ANALYSIS;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DOUBLE-BLIND METHOD; FEMALE; GLUTAMINE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFUSIONS, PARENTERAL; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; TRANSPLANTATION, AUTOLOGOUS;

EID: 0036438698     PISSN: 12107913     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Gratama, J. W., Lipovich-Oosterveer, M. A., Willemze, R. et al.: Reduction and repopulation of T-lymphocytes after cytoreductive therapy with or without autologous bone marrow rescue. Exp. Hematol, 14, 1986, s. 173-177.
2. Ziegler, T. R., Bye, R. L., Persinger, R. D. et al.: Effects of glutamine supplementation on circulating lymphocytes after bone marrow transplantation: a pilot study. Am. J. Med. Sci. 315, 1998, s. 4-10.
3. Ardawi, M. S. M.: Glutamine and glucose metabolism in human peripheral lymphocytes. Metabolism, 37, 1988, s. 99-103.
4. Calder, P. C.: Glutamine and the immune system. Clin. Nutr. 13, 1994, s. 2-8.
5. Crawford, J., Cohen, H. J.: The essential role of L-glutamine in lymphocyte differentiation in vitro. J. Cell. Physiol. 124, 1985, s. 275-282.
6. Ziegler, T. R., Young, L. S., Benfels, K. et al.: Clinical and metabolical efficacy of glutamine-supplemented parenteral nutrition following bone marrow transplantation: a randomized, double-blind controlled study. Ann. Intern. Med. 116, 1992, s. 821-828.
7. Anderson, P. M., Ramsay, N. K. C., Shu, X. O. et al.: Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation. Bone Marrow Transplant. 22, 1988, s. 339-344.
8. Coghlin Dickson, T. M., Wong, R. M., Offrin, R. S. et al.: Effect of oral glutamine during bone marrow transplantation. J. Parenter. Enteral. Nutr. 24, 2000, s. 61-66.
9. Cockerham, M. B., Weinberg, B. B., Lergie, S. B.: Oral glutamine for the prevention of oral mucositis associated with high-dose paclitaxel and melphalan for autologous bone marrow transplantation. Ann. Pharmacother. 34, 2000, s. 300-303.
10. San Miguel, J. F., Hernandez, M. D., Gonzalez, M. et al.: A randomized study comparing the effect of GM-CSF and G-CSF on immune reconstitution after autologous bone marrow transplantation. Br. J. Haematol. 94, 1996, s. 140-147.
11. Champlin, R. E., Schmitz, N., Horowitz, M. M. et al.: Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation: IBMTR Histocompatibility and Stem Cell Sources Working Comittee and the European Group for Blood and Marrow Transplantation (EBMT). Blood. 95, 2000, s. 3702-3709.
12. Protheroe, A. S., Pickard, C. Johnson, P. W. et al.: Persistence of clonal T-cell expansions following high-dose chemotherapy and autologous peripheral blood progenitor rescue. Br. J. Hamatol. 111, 2000, s. 766-773.